S1 Technology
Our Proprietary Original Technology
- Composite bone grafting material composed of chemically and structurally treated
- hydroxyapatite and additives with a natural structure similar to human bone.
- It has osteoconductive Properties that aid bone regeneration at the grafted site.
- This core technology is applicable to all medical fields (orthopedics, neurology, dentistry, etc.)
- and various raw materials (xenogeneic, allogeneic, synthetic).
Facility
1st, 2nd, and 3rd Factory construction completed
World's First: European CE Certification for 3 Biomaterial Products
Separate Manufacturing Facilities for Different Raw Materials in Factories 1–3
-
1st Factory / HQ
[Bone Graft Material Line]
-
2nd Factory / R&D Center
[Bone Graft + Collagen Line]
-
3rd Factory
[Artificial Skin + Other Medical Field]
R&D Facilities / Certifications / Patents
Commercialized technology Global IP (intellectual property rights)
holding a total of 46 or more
Overseas
32
PCT application
4US application
8European application
8China application
4Taiwan application
6Madrid trademark application
1Chinese design application
1
0or more in total
Domestic